The INAHTA Board of Directors is composed of a diverse representation of the INAHTA membership.  The Board is responsible for guiding the overall direction and activities of the Network and Secretariat toward the implementation of the INAHTA Strategic Plan. The members of the Board are representatives of an INAHTA member agency and they are elected by the membership for 2-year terms.

INAHTA Board Members

Prof. Tracy Merlin, AHTA, Australia, Chair (2020-2022)
Dr. Mouna Jameleddine, INEAS, Tunisia, Vice-Chair (Aug. 2021-2022), Director (2020-Aug. 2021)
Dr. Matthias Perleth, G-BA, Germany, Treasurer (2020-2022)
Chantal Guilhaume, PharmD, HAS, France, Director (2021-2023)
Karen Macpherson, MPH, HIS, UK, Director (2020-2022)
Dr. Juan Antonio Blasco Amaro, AETSA, Spain, Director (Aug. 2021-2022)
Alric Rüther, Dr. med, IQWiG, Germany, Director (2021-2023)
Dr. Sophie Söderholm Werkö, SBU, Sweden, Past Chair (2020-2022) (Ex officio)
-> View Board member profiles below
-> View Board Competing and Conflict of Interest (CCI) forms below



Prof. Tracy Merlin, AHTA, Australia
Chair (2020-2022)

View profile
View CCI Form



Dr. Mouna Jameleddine, INEAS, Tunisia
Vice-Chair (Aug. 2021-2022)
Director (2020-Aug. 2021)

View profile
View CCI Form

 


Dr. Matthias Perleth, G-BA, Germany
Treasurer (2020-2022)

View profile
View CCI Form


Chantal Guilhaume, PharmD, HAS, France
Director (2021-2023)
View profile
View CCI Form


Karen Macpherson, MPH HIS, UK
Director (2020-2022)

View profile
View CCI Form


Dr. Juan Antonio Blasco Amaro, AETSA, Spain
Director (Aug 2021-2022)

View profile
View CCI Form


 

Alric Rüther, Dr. med, IQWiG, Germany
Director (2021-2023)

View profile
View CCI Form



Dr. Sophie Söderholm Werkö, SBU, Sweden
Past Chair (2020-2022)
(Ex officio)
View profile